Scinai Immunotherapeutics
Innovative Immunotherapeutic Treatments
StartupScinai Immunotherapeutics is a Jerusalem-based startup in the Health Tech & Life Sciences sector, established in 2003. Innovative Immunotherapeutic Treatments. The company has raised a total of $63.94M across 12 funding rounds, currently at the Public stage. Key investors include Undisclosed Investor(s). The company has 11-50 employees. Core technologies: Biologicals, Molecules.
With $63.94M in total funding, Scinai Immunotherapeutics is a Public-stage company operating in Health Tech & Life Sciences. The company follows a B2B2C/B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StagePublic
- ProductClinical Trial
- ModelB2B2C, B2B
- Employees11-50
- HQJerusalem
- DistrictJerusalem District
- Last Round$246K
- Undisclosed Investor(s)
114 articles covered by sources including www.prnewswire.com,
finance.yahoo.com,
en.globes.co.il,
scr.zacks.com,
www.globes.co.il.
What does Scinai Immunotherapeutics do?
Scinai Immunotherapeutics is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb) pipeline targeting diseases with large unmet medical needs.
How much funding has Scinai Immunotherapeutics raised?
Scinai Immunotherapeutics has raised $63.94M in total funding across 12 rounds. The company is currently at the Public stage. Key investors include Undisclosed Investor(s).
What sector is Scinai Immunotherapeutics in?
Scinai Immunotherapeutics operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Molecules. Target customers: Healthcare & Life Sciences, Healthcare, Providers, Patients, Life Sciences, Pharmaceuticals.
Where is Scinai Immunotherapeutics located?
Scinai Immunotherapeutics is based in Jerusalem BioPark, Hadassah Ein Kerem Campus, Jerusalem District.